WitteCL, ChungYC, WitteMH, . Observations on the origin of ascites from experimental extrahepatic portal congestion. Ann Surg1969;170:1002–15.
2.
BarrowmanJA, GrangerDN. Effects of experimental cirrhosis on splanchnic microvascular fluid and solute exchange in the rat. Gastroenterology1984;87:165–72.
3.
WitteMH, WitteCL, DumontAE. Estimated net transcapillary water and protein flux in the liver and intestine of patients with portal hypertension from hepatic cirrhosis. Gastroenterology1981;80:265–72.
4.
GrangerDN, MillerT, AllenR, . Permselectivity of cat liver blood-lymph barrier to endogenous macromolecules. Gastroenterology1979;77:103–9.
5.
WitteMH, WitteCL, DumontAE. Progress in liver disease: physiological factors involved in the causation of cirrhotic ascites. Gastroenterology1971;61:742–50.
6.
WitteCL, WitteMH, DumontAE. Lymph imbalance in the genesis and perpetuation of the ascites syndrome in hepatic cirrhosis. Gastroenterology1980;78:1059–68.
7.
WitteCL, WitteMH, DumontAE, . Protein content in lymph and edema fluids in congestive heart failure. Circulation1969;40:623–30.
8.
SchaffnerF, PopperH.Capillarization of hepatic sinusoids in man. Gastroenterology1963;44:239–42.
9.
AtkinsonM, LosowskyMS. The mechanism of ascites formation in chronic liver disease. Q JM1961;30:153–66.
10.
BoschJ, EnriquezR, GroszmannRJ, . Chronic bile duct ligation in the dog: hemodynamic characterization of a portal hypertensive model. Hepatology1983;3:1002–7.
11.
VorobioffJ, BredfeldtJE, GroszmannRJ. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol1983;244:G52–7.
12.
VorobioffJ, BredfeldtJE, GroszmannRJ. Increased blood flow through the portal system in cirrhotic rats. Gastroenterology1984;87:1120–6.
13.
BenoitJN, GrangerDN. Intestinal microvascular adaptation to chronic portal hypertension in the rat. Gastroenterology1988;94:471–6.
14.
KorthuisRJ, KindenDA, BrimerGE, . Intestinal capillary filtration in acute and chronic portal hypertension. Am J Physiol1988;254:G339–45.
15.
RectorWGJr. Portal hypertension: a permissive factor only in the development of ascites and variceal bleeding. Liver1986;6:221–6.
16.
MoraliGA, SnidermanKW, DeitelKM, . Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites?J Hepatol1992;16:249–50.
17.
GinesP, Fernandez-EsparrachG, ArroyoV, RodesJ.Pathogenesis of ascites in cirrhosis. Semin Liver Dis1997;17: 175–89.
18.
BoschJ, ArroyoV, BetriuA, . Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology1980;78:92–9.
19.
CastellsA, SaloJ, PlanasR, . Impact of shunt surgery for variceal bleeding in the natural history of ascites in cirrhosis: a retrospective study. Hepatology1994;20:584–91.
20.
OchsA, RossleM, HaagK, . The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med1995;332:1192–7.
21.
KowalskiHJ, AbelmannWH. The cardiac output at rest in Laennec's cirrhosis. J Clin Invest1953;32:1025–33.
22.
MurrayJF, DawsonAM, SherlockS.Circulatory changes in chronic liver disease. Am J Med1958;24:358–67.
23.
LiebermanFL, DenisonEK, ReynoldsTB. The relationship of plasma volume, portal hypertension, ascites, and renal sodium retention in cirrhosis: the overflow theory of ascites formation. Ann NY Acad Sci1970;170:202–11.
24.
LevyM.Sodium retention and ascites formation in dogs with experimental portal cirrhosis. Am J Physiol1977;233:F572–85.
25.
LevyM, AlloteyJB. Temporal relationships between urinary salt retention and altered systemic hemodynamics in dogs with experimental cirrhosis. J Lab Clin Med1978;92:560–569.
26.
LevyM, WexlerMJ. Renal sodium retention and ascites formation in dogs with experimental cirrhosis but without portal hypertension or increased splanchnic vascular capacity. J Lab Clin Med1978;91:520–36.
27.
UnikowskyB, WexlerMJ, LevyM.Dogs with experimental cirrhosis of the liver but without intrahepatic hypertension do not retain sodium or form ascites. J Clin Invest1983;72:1594–604.
28.
LopezC, JimenezW, ArroyoV, . Temporal relationship between the decrease in arterial pressure and sodium retention in conscious spontaneously hypertensive rats with carbon tetrachloride-induced cirrhosis. Hepatology1991;13:585–9.
29.
SawchenkoPE, FriedmanMI. Sensory functions of the liver: a review. Am J Physiol1979;236:R5–20.
30.
AndrewsWHH, PalmerJF. Afferent nervous discharge from the canine liver. QJ Exp Physiol1967;52:269–76.
31.
LevyM, WexlerMJ. Hepatic denervation alters first-phase urinary sodium excretion in dogs with cirrhosis. Am J Physiol1987;253:F664–71.
32.
LevyM, WexlerMJ. Sodium excretion in dogs with low-grad caval constriction: role of hepatic nerves. Am J Physiol1987;253:F672–8.
33.
KostrevaDR, CastanerA, KampineJP. Reflex effects of hepatic baroreceptors on renal and cardiac sympathetic nerve activity. Am J Physiol1980;238-4.
34.
AndersonRJ, CroninRE, McDonaldKM, SchrierRW. Mechanisms of portal hypertension-induced alterations in renal hemodynamics, renal water excretion, and renin secretion. J Clin Invest1976;58:964–70.
35.
BankirL, MartinH, DechauxM, AhloulayM.Plasma cAMP: a hepatorenal link influencing proximal reabsorption and renal hemodynamics?Kidney Int1997;51 (suppl 59):S50–6.
36.
RectorWG, HossackKF. Pathogenesis of sodium retention complicating cirrhosis: is there room for diminished effective arterial blood volume?Gastroenterology1988;95:1658–63.
37.
WilkinsonSP, JowettJP, SlaterJD, ArroyoV, MoodieH, WilliamsR.Renal sodium retention in cirrhosis: relation to aldosterone and nephron site. Clin Sci1979;56:169–77.
38.
ArroyoV, BoschJ, MauriM, . Renin, aldosterone and renal hemodynamics in cirrhosis with ascites. Eur J Clin Invest1979;9:69–73.
39.
WolffHP, KoczorekKR, BuchbornE.Aldosterone and antidiuretic hormone (Adiuretin) in liver disease. Acta Endocrinol (Copenh)1958:27:45–58.
40.
AlpernRJ. Renal sodium retention in liver disease. (Medical Staff Conference, University of California, San Francisco) West J Med1983;138:852–60.
41.
BoschJ, ArroyoV, BetriaA, . Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology1980;78:92–9.
42.
RosoffL, ZiaP, ReynoldsT, HortonR.Studies of renin and aldosterone in cirrhotic patients with ascites. Gastroenterology1975;69:698–705.
43.
CipleaA, BubuianuE.Cerebrospinal fluid-, blood-, and ascites-catecholamines in hepatic cirrhosis. Physiologie1979;16:19–24.
44.
HenriksenJH, ChristensenNJ, Ring-LarsenH.Noradrenalin and adrenalin concentrations in various vascular beds in patients with cirrhosis: relation to haemodynamics. Clin Physiol1981;1:293–304.
45.
BichetDG, Van PuttenVJ, SchrierRW. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med1982;307:1552–7.
46.
BichetDG, SzatalowiczV, ChaimovitzC, SchrierRW. Role of vasopressin in abnormal water excretion in cirrhotic patients. Ann Intern Med1982;96:413–7.
47.
Perez-AyusoRM, ArroyoV, CampsJ.Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis. Kidney Int1984;26:72–80.
48.
NichollsKM, ShapiroMD, GrovesBS, SchrierRW. Factors determining renal response to water immersion in nonexcretor cirrhotic patients. Kidney Int1986;30:417–21.
49.
MollerS, HenriksenJH. Circulatory abnormalities in cirrhosis with focus on neurohumoral aspects. Semin Nephrol1997;17:505–19.
50.
HenriksenJH, BendtsenF, SorensonTIA, . Reduced central blood volume in cirrhosis. Gastroenterology1989;97:1506–13.
51.
HenriksenJH, BendtsenF, GerbesAL, . Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, b-adrenergic blockade and atrial natriuretic factor. Hepatology1992;5:1163–70.
52.
EpsteinM.Cardiovascular and renal effects of head-out water immersion in man. Circ Res1976;39:619–28.
53.
EpsteinM.Deranged sodium homeostasis in cirrhosis. Gastroenterology1979;76:622–35.
54.
EpsteinM.Renal effects of head-out immersion in man: implications for an understanding of volume homeostasis. Physiol Rev1978;58:529–81.
55.
EpsteinM, LevinsonR, SanchoJ, HaberE, ReR.Characterization of the renin-aldosterone system in decompensated cirrhosis. Circ Res1977;41:818–29.
56.
EpsteinM, PinsDS, SchneiderN, LevinsonR.Determinants of deranged sodium and water homeostasis in decompensated cirrhosis. J Lab Clin Med1976;87:822–39.
57.
BichetDG, GrovesBM, SchrierRW. Mechanisms of improvement of water and sodium excretion by immersion in decompensated cirrhotic patients. Kidney Int1983;24:788–94.
58.
NichollsKM, ShapiroMD, Van PuttenVJ, . Elevated plasma norepinephrine concentrations in decompensated cirrhosis. Circ Res1985;56:457–61.
59.
BlendisLM, GreigPD, LongerB, BaigrieRS, RuseJ, TaylorBR. The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites. Gastroenterology1979;77:250–7.
60.
QuirogaJ, SangroB, NunezM, . Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology1995;21:986–94.
61.
GinesP, TitoL, ArroyoV, . Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology1988;94:1493–1502.
62.
BetterO.Renal and cardiovascular dysfunction in liver disease. Kidney Int1986;29:598–607.
63.
PaluCD, DonaggioG, ZottoID, PessinaAC. Arteriovenous shunts in cirrhotic patients studied with human serum albumin macroaggregates tagged with 1131 (MAA 1311). Scand J Gastroenterol1968;3:425–31.
64.
KontosHA, ShapiroW, MauckHP, PattersonJL. General and regional circulatory alterations in cirrhosis of the liver. Am J Med1964;37:526–35.
65.
ManentiF, WilliamsR.Injection studies of the splenic vasculature in portal hypertension. Gut1966;7:175–80.
66.
EpsteinFH, PostRS, McDowellM.The effect of an arteriovenous fistula on renal hemodynamics and electrolyte excretion. J Clin Invest1953;32:233–41.
67.
LimasCJ, GuihaNH, LekagulO, CohnJN. Impaired left ventricular function in alcoholic cirrhosis with ascites. Circulation1974;69:755–60.
68.
CarameloC, Fernandez-MunozD, SantosJC, . Effect of volume expansion on hemodynamics, capillary permeability and renal function in conscious, cirrhotic rats. Hepatology1986;6:129–34.
69.
SanzE, CarameloC, Lopez-NovoaJM. Interstitial dynamics in rats with early stage experimental cirrhosis of the liver. Am J Physiol1989:256:F497–503.
70.
SchrierRW. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy. N Engl J Med1988;319:1065–72 and 1127–34.
71.
SchrierRW, ArroyoV, BernardiM, EpsteinM, HenriksenJH, RodesJ.Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention. J Hepatol1987;6:239–57.
72.
AlbillosA, ColombatoLA, GroszmannRJ. Vasodilatation and sodium retention in prehepatic portal hypertension. Gastroenterology1992;102:931–5.
73.
Fernandez-MunozD, CarameloC, SantosJC, BlanchartA, HernandoL, Lopez-NovaJM. Systemic and splanchnic hemodynamic disturbances in conscious rats with experimental liver cirrhosis without ascites. Am J Physiol1985;249:G316–20.
74.
ShapiroMD, NichollsKM, GrovesBM, . Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients. Kidney Int1985;28:206–11.
75.
SatoS, OhnishiK, SugitaS, OkudaK.Splenic artery and superior mesenteric artery blood flow: nonsurgical doppler US measurement in healthy subjects and patients with chronic liver disease. Radiology1987;164:347–52.
76.
IwaoT, ToyonagaA, SatoM, OhoK, SakaiT, TayamaC, NakanoR, TanikawaK.Effect of posture-induced blood volume expansion on systemic and regional hemodynamics in patients with cirrhosis. J Hepatol1997;27:484–91.
77.
ColombatoL, AlbillosA, GroszmannR.The role of blood volume in the development of sodium retention in portal hypertensive rats. Gastroenterology1996;110:193–8.
78.
LenzK, DrumlW, HortnaglH, . Improvement of renal haemodynamics in decompensated cirrhosis with ornipressin. J Hepatol1989;9(1 Suppl):S181.
79.
LenzK, HortnaglH, DrumlW, . Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Gastroenterology1991;101:1060–7.
80.
GuevaraM, GinesP, Fernandez-EsparrachG, . Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology1988;27:35–41.
81.
LaffiG, FoschiM, MasiniE, . Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. Hepatology1995;22:1666–73.
82.
RosJ, JimenezW, LamasS, ClariaJ, ArroyoV, RiveraF, RodesJ.Nitric oxide production in arterial vessels of cirrhotic rats. Hepatology1995;21:554–60.
83.
SogniP, GarnierP, GadanoA, MoreauR, Dall'Ava-SantucciJ, Dinh-XuanAT, LebrecD.Endogenous pulmonary nitric oxide production measured from exhaled air is increased in patients with severe cirrhosis. J Hepatol1995;23:471–3.
84.
WeigertAL, MartinP-Y, SchrierRW. Vascular hyporesponsiveness in cirrhotic rats: role of different nitric oxide synthase isoforms. Kidney Int1997;52 (suppl 61):S41–4.
85.
NiederbergerM, GinesP, TsaiP, . Increased aortic cyclic guanosine monophosphate concentration in experimental cirrhosis in rats: evidence for a role of nitric oxide in the pathogenesis of arterial vasodilation in cirrhosis. Hepatology1995;21:1625–31.
86.
CampilloB, ChabrierP-E, PelleG, SediameS, AtlanG, FouetP, AdnotS.Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis. Hepatology1995;22:1423–9.
87.
NiederbergerM, MartinP-Y, GinesP, . Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology1995;109:1624–30.
88.
MartinP-Y, OharaM, GinesP, XuD-L, St. JohnJ, NiederbergerM, SchrierRW. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites. J Clin Invest1998;101:235–42.
89.
Lopez-TalaveraJC, MerrillWM, GroszmannRJ. Tumor necrosis factor a: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology1995;108:761–7.
90.
Lopez-TalaveraJC, LevitzkiA, MartinezM, . Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites. J Clin Invest1997;100:664–70.
91.
Chin-DustingJPF, RasaratanamB, JenningsGLR, . Effect of fluoroquinolone on the enhanced nitric oxide-induced peripheral vasodilation seen in cirrhosis. Ann Intern Med1997;127:985–8.
92.
MartinP, GinesP, SchrierR.Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med1998;339:533–41.
93.
PapadakisMA, ArieffAI. Unpredictability of clinical evaluation of renal function in cirrhosis. Am J Med1987;82:945–52.
94.
BoyerTD, WarnockDG. Use of diuretics in the treatment of cirrhotic ascites. Gastroenterology1983;84:1051–5.
95.
WongF, MassieD, ColmanJ, DudleyF.Glomerular hyperfiltration in patients with well-compensated alcoholic cirrhosis. Gastroenterology1993;104:884–9.
96.
KlinglerE, VaamondeCA, VaamondeLS, . Renal function changes in cirrhosis of the liver. Arch Intern Med1970;125:1010–5.
97.
ChiandussiL, BartoliE, ArrasS.Reabsorption of sodium in the proximal renal tubule in cirrhosis of the liver. Gut1978;19:497–503.
98.
SchedlHP, BartterFC. An explanation for an experimental correction of the abnormal water diuresis in cirrhosis. J Clin Invest1960;39:248–61.
99.
AngeliP, GattaA, CaregaroL, . Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance. Eur J Clin Invest1990;20:111–7.
100.
WoodLJ, MassieD, McLeanAJ, DudleyFJ. Renal sodium retention in cirrhosis: Tubular site and relation to hepatic dysfunction. Hepatology1988;8:831–6.
101.
EarleyLE, MartinoJA. Influence of sodium balance on the ability of diuretics to inhibit tubular reabsorption. Circulation1970:42:323–34.
102.
BankN, AynedjianHS. A micropuncture study of renal salt and water retention in chronic bile duct obstruction. J Clin Invest1975;55:994–1002.
103.
BetterOS, MassrySG. Effect of chronic bile duct obstruction on renal handling of salt and water. J Clin Invest1972;51:402–11.
104.
MelmanA, MassrySG. Role of renal vasodilation in the blunted natriuresis of saline infusion in dogs with chronic bile duct obstruction. J Lab Clin Med1977;89:1053–65.
105.
ChaimovitzC, SzylmanP, AlroyG, BetterOS. Mechanism of increased renal tubular sodium reabsorption in cirrhosis. Am J Med1972:52:198–202.
106.
EpsteinM, RamachandranM, De NunzioAG. Interrelationship of renal sodium and phosphate handling in cirrhosis. Miner Electrolyte Metab1982;7:305–15.
107.
Perez-AyusoRM, ArroyoV, PlanasR, . Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Gastroenterology1983;84:961–8.
108.
LevyM.Sodium retention in dogs with cirrhosis and ascites: efferent mechanisms. Am J Physiol1977;233:F586–92.
109.
DiBonaGF, HermanPJ, SawinLL. Neural control of renal function in edema-forming states. Am J Physiol1988;254:R1017–24.
110.
DiBonaGF, SawinLL. Role of renal nerves in sodium retention of cirrhosis and congestive heart failure. Am J Physiol1991;260:R298–305.
111.
KoepkeJP, JonesS, DiBonaGF. Renal nerves mediate blunted natriuresis to atrial natriuretic peptide in cirrhotic rats. Am J Physiol1987;252:R1019–23.
112.
Rodriguez-MartinezM, SawinLL, DiBonaGF. Arterial and cardiopulmonary baroreflex control of renal nerve activity in cirrhosis. Am J Physiol1995;268:R117–29.
113.
MatsudaT, MoritaH, HosomiH, OkadaM.Response of renal nerve activity to high NaCl food intake in dogs with chronic bile duct ligation. Hepatology1996;23:303–9.
114.
Ring-LarsenH, HesseB, HenriksenJH, ChristensenNJ. Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis: plasma norepinephrine concentration, hepatic extraction, and renal release. Hepatology1982;2:304–10.
115.
EpsteinM, LariosO, JohnsonG.Effects of water immersion on plasma catecholamines in decompensated cirrhosis. Implications for deranged sodium and water homeostasis. Miner Electrolytes Metab1985;11:25–34.
116.
EslerM, DudleyF, JenningsG, . Increased sympathetic nervous activity and the effects of its inhibition with clonidine in alcoholic cirrhosis. Ann Intern Med1992;116:446–55.
117.
RoulotD, MoreauR, GaudinC, . Long-term sympathetic and hemodynamic responses to clonidine in patients with cirrhosis and ascites. Gastroenterology1992;102:1309–18.
118.
BetterO, SchrierRW. Disturbed volume homeostasis in patients with cirrhosis of the liver. Kidney Int1983;23:303–11.
119.
DiBonaGF. Renal neural activity in hepatorenal syndrome. Kidney Int1984;25:841–53.
120.
Ring-LarsenH, HenriksenJH, ChristensenNJ. Increased sympathetic activity in cirrhosis. N Engl J Med1983;308:1029.
EpsteinM, BerkDP, HollenbergNK, . Renal failure in the patient with cirrhosis. Am J Med1970;49:175–85.
123.
ChonkoAM, BayWH, SteinJ, FerrisTF. The role of renin and aldosterone in the salt retention of edema. Am J Med1977;63:881–9.
124.
EpsteinM, LevinsonR, SanchoJ, HaberE, ReR.Characterization of the renin-aldosterone system in decompensated cirrhosis. Circ Res1977;41:818–29.
125.
EpsteinM.Renal sodium handling in liver disease. In: EpsteinM, ed. The kidney in liver disease: 3rd ed. Baltimore: Williams … Wilkins, 1988:3–30.
126.
EggertRC. Spironolactone diuresis in patients with cirrhosis and ascites. Br Med J1970;4:401–3.
127.
NichollsKM, ShapiroMD, KlugeR, ChungH, BichetDG, SchrierRW. Sodium excretion in advanced cirrhosis: effect of expansion of central blood volume and suppression of plasma aldosterone. Hepatology1986;6:235–8.
128.
BernardiM, Di MarcoC, TrevisaniF, . Renal sodium retention during upright posture in preascitic cirrhosis. Gastroenterology1993;105:188–93.
129.
ZambraskiEJ, DunnMJ. Importance of renal prostaglandins in control of renal function after chronic ligation of the common bile duct in dogs. J Lab Clin Med1984;103:549–59.
130.
ArroyoV, PlanasR, GayaJ, . Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion. Eur J Clin Invest1983;13:271–8.
131.
BoyerTD, ZiaP, ReynoldsTB. Effect of indomethacin and prostaglandin Al on renal function and plasma renin activity in alcoholic liver disease. Gastroenterology1979;77:215–22.
132.
MirouzeD, ZisperRD, ReynoldsTB. Effects of inhibitors of prostaglandin synthesis on induced diuresis in cirrhosis. Hepatology1983;3:50–5.
133.
EpsteinM, LifschitzM, RamachandranM, RappaportK.Characterization of renal PGE responsiveness in decompensated cirrhosis: implications for renal sodium handling. Clin Sci1982;63:555–63.
134.
LaraghJH, CannonPJ, BentzelCJ, SicinskiAM, MeltzerJI. Angiotensin II, norepinephrine, and renal transport of electrolytes and water in normal man and in cirrhosis with ascites. J Clin Invest1963:42:1179–92.
135.
ZipserRD, HoefsJC, SpeckartPF, ZiaPK, HortonR.Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease. J Clin Endocrinol Metab1979;48:895–900.
136.
PalmerBF. Renal complications associated with use of non-steroidal anti-inflammatory agents. J Investig Med1995;43:516–33.
137.
Perez-AyusoRM, ArroyoV, CampsJ, . Renal kallikrein excretion in cirrhosis with ascites: relationship to renal hemodynamics. Hepatology1984;4:247–52.
138.
MacGilchristA, CraigKJ, HayesPC, CummingAD. Effect of the serine protease inhibitor, aprotinin, on systemic haemodynamics and renal function in patients with hapatic cirrhosis and ascites. Clin Sci1994:87:329–35.
139.
WirthKJ, BickelM, HropotM, GunzlerV, HeitschH, RuppertD, ScholkensBA. The bradykinin B2 receptor antagonist Icatibant (HOE 140) corrects avid Na+ retention in rats with CCL4-induced liver cirrhosis: possible role of enhanced microvascular leakage. Eur J Pharmacol1997;337:45–53.
140.
AtlasSA, EpsteinM.Atrial natriuretic factor: implications in cirrhosis and other edematous disorders. In: EpsteinM, ed. The kidney in liver disease: 3rd ed. Baltimore: Williams … Wilkins, 1988:429–55.
141.
JimenezW, Martinez-PardoA, ArroyoV, GayaJ, RiveraF, RodesJ.Atrial natriuretic factor: reduced cardiac content in cirrhotic rats with ascites. Am J Physiol1986;250:F749–52.
142.
SkoreckiKL, LeungWM, CampbellP, . Role of atrial natriuretic peptide in the natriuretic response to central volume expansion induced by head-out water immersion in sodium-retaining cirrhotic subjects. Am J Med1988;85:375–82.
143.
MaherE, CernacekP, LevyM.Heterogeneous renal responses to atrial natriuretic factor II. Cirrhotic dogs. Am J Physiol1989;257:R1068–74.
144.
GerbesAL, KollendaMC, VollmarAM, ReichenJ, VakilN, ScarboroughRM. Altered density of glomerular binding sites for atrial natriuretic factor in bile duct-ligated rats with ascites. Hepatology1991;13:562–6.
145.
PanosMZ, GoveC, FirthJD, RaineAEG, LedinghamJGG, WestabyD, WilliamsR.Impaired natriuretic response to atrial natriuretic peptide in the isolated kidney of rats with experimental cirrhosis. Clin Sci1990;79:67–71.
146.
LegaultL, CernacekP, LevyM, MaherE, FarberD.Renal tubular responsiveness to atrial natriuretic peptide in sodium-retaining chronic caval dogs: a possible role for kinins and luminal actions of the peptide. J Clin Invest1992;90:1425–35.
147.
LopezC, JimenezW, ArroyoV, . Role of altered systemic hemodynamics in the blunted renal response to atrial natriuretic peptide in rats with cirrhosis and ascites. J Hepatol1989;9:217–26.
148.
MoraliGA, TobeSW, SkoreckiKL, BlendisLM. Refractory ascites: modulation of atrial natriuretic factor unresponsiveness by mannitol. Hepatology1992;16:42–8.
149.
La VillaG, RiccardiD, LazzeriC, . Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention. Hepatology1995:22:1745–50.
150.
Fernandez-RodriguezC, PradaI, PrietoJ, MontuengaL, ElssasserT, QuirogaJ, MoreirasM, AndradeA, CuttittaF.Circulating adrenomedullin in cirrhosis: relationship to hyperdynamic circulation. J Hepatol1998;98:250–6.
151.
SaloJ, JimenezW, KuhnM, . Urinary excretion of urodilatin in patients with cirrhosis. Hepatology1996;24:1428–32.
152.
MooreK, WendonJ, FrazerM, KaraniJ, WilliamsR, BadrK.Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 327:1774–8.
153.
RunyonBA. Care of patients with ascites. N Engl J Med1994;330:337–42.
154.
Ring-LarsenH, HenriksenJH, WilkenC, . Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture. Br Med J1986;292:1351–3.
155.
TrevisaniF, BernardiM, GasbarriniG, . Bed-rest-induced hypernatriuresis in cirrhotic patients without ascites: does it contribute to maintain 'compensation'?J Hepatol1992;16:190–6.
156.
SaloJ, GuevaraM, Fernandez-EsparrachG, . Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems. Hepatology1997;25:1338–42.
157.
PinzaniM, DaskalopoulosG, LaffiG, . Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance. Gastroenterology1987;92:294–6.
158.
BraterDC. Diuretic therapy. N Engl J Med1998;339:387–95.
159.
Garcia-PaganJC, SalmeronJM, FeuF, . Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis. Hepatology1994;19:1095–9.
160.
PockrosPJ, ReynoldsTB. Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema. Gastroenterology1986;90:1827–33.
161.
RunyonBA. Patient selection is important in studying the impact of large-volume paracentesis on intravascular volume. Am J Gastroenterol1997;92:371–3.
162.
RunyonBA. Management of adult patients with ascites caused by cirrhosis. Hepatology1998;27:264–72.
163.
PozziM, OsculatiG, BoariG, . Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites. Gastroenterology1994;106:709–19.
164.
LucaA, FeuF, Garcia-PaganJC, . Favorable effects of total paracentesis on splanchnic hemodynamics in cirrhotic patients with tense ascites. Hepatology1994;20:30–3.
165.
KravetzD, RomeroG, ArgonzJ, . Total volume paracentesis decreases variceal pressure, size, and variceal wall tension in cirrhotic patients. Hepatology1997;25:59–62.
166.
GinesP, TitoL, ArroyoV, . Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology1988;94:1493–1502.
167.
GinesA, Fernandez-EsparrachG, MonescilloA, . Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology1996;111:1002–10.
168.
LucaA, Garcia-PaganJC, BoschJ, . Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis. Hepatology1995;22:753–8.
169.
PintoPC, AmerianJ, ReynoldsTB. Large-volume paracentesis in nonedematous patients with tense ascites: its effect on intravascular volume. Hepatology1988;8:207–10.
170.
PeltekianKM, WongF, LiuPP, . Cardiovascular, renal, and neurohormonal responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites. Am J Gastroenterol1997;92:394–9.
171.
MollerS, BendtsenF, HenriksenJH. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology1995;109:1917–25.
172.
EpsteinM.Peritoneovenous shunt in the management of ascites and the hepatorenal syndrome. Gastroenterology1982;82:790–9.
StanleyMM, OchiS, LeeKK, Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N Engl J Med1989;321:1632–8.
175.
GinesP, ArroyoV, VargasV, . Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med1991;325:829–35.
176.
SombergKA, LakeJR, TomlanovichSJ, . Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology1995;21:709–16.
177.
WongF, SnidermanK, LiuP, . The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology1997;112:899–907.
178.
WongF, SnidermanK, LiuP, . Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med1995;122:816–22.
179.
GuevaraM, GinesP, BandiJ, GilabertR, SortP, JimenezW, Garcia-PaganJ, BoschJ, ArroyoV, RodesJ.Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology1998;28:416–22.
180.
LebrecD, GiuilyN, HadengueA, . Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol1996;25:135–44.
181.
SanyalAJ, FreedmanAM, LuketicVA, . The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology1997;112:889–98.